BRANDI EGIZIO: Open Payments
NPI 1043229107 · CEDAR PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,976 in 177 payments from 21 companies in 2025. Trend: 2023 $4,111 · 2024 $4,435 · 2025 $3,976
Food & beverage: $3,867Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $657 |
| Janssen Biotech, Inc. | 22 | $448 |
| Regeneron Pharmaceuticals, Inc. | 3 | $389 |
| GENZYME CORPORATION | 10 | $382 |
| PFIZER INC. | 15 | $317 |
| UCB, Inc. | 13 | $314 |
| Novartis Pharmaceuticals Corporation | 14 | $308 |
| Regeneron Healthcare Solutions, Inc. | 21 | $264 |
| LEO Pharma Inc. | 12 | $229 |
| Amgen Inc. | 7 | $141 |
Products named: DUPIXENT, TREMFYA, RINVOQ, Bimzelx, CIBINQO, COSENTYX, ADBRY, SKYRIZI.
Industry payments across TX — which companies pay providers there.
